|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.1 CAD | -4.76% |
|
0.00% | +400.00% |
| Apr. 26 | BioNeutra Global Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Feb. 08 | BioNeutra Global Corporation Appoints Stephen Jakeway as Chief Operating Officer | CI |
BioNeutra Global Corporation filed its Annual on Apr 28, 2022 for the period ending Dec 31, 2021. In this report its auditor, Kenway Mack Slusarchuk Stewart LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
| 1st Jan change | Capi. | |
|---|---|---|
| +400.00% | 3.41M | |
| -4.93% | 261B | |
| -2.51% | 94.98B | |
| +3.19% | 46.39B | |
| +8.74% | 39.99B | |
| -0.65% | 39.95B | |
| -0.15% | 38.02B | |
| -16.78% | 30.16B | |
| -6.61% | 28.72B | |
| +11.32% | 24.54B |
BIONEUTRA GLOBAL CORPORATION 
